跳至主要内容
临床试验/NCT05559892
NCT05559892进行中(未招募)不适用

Conditional Cash Transfer Intervention to Improve Health Outcomes Among Inner-City African Americans With T2DM

State University of New York at Buffalo2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
2
主要终点
Glycemic control (HbA1c)

研究概览

简要总结

This study will test the preliminary efficacy of diabetes-tailored CCT (DM-CCT), which will be conditional on participating in biweekly (every two weeks), nurse-led, virtual diabetes education/skills training and stress/coping intervention compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in 100 inner city AAs with poorly controlled T2DM using an RCT design. The aims of the proposed study include:

AIM 1: Test the preliminary efficacy of the DM-CCT intervention on glycemic control and quality of life for inner-city AAs with T2DM.

AIM 2: Test the preliminary efficacy of the DM-CCT intervention on self-care behaviors and psychological health for inner-city AAs with T2DM.

AIM 3: Estimate the cost of delivery of the DM-CCT and UCT interventions in preparation for future cost effectiveness analysis.

详细描述

The overarching aim of this proposal is to test the preliminary efficacy of diabetes-tailored CCT (DM-CCT conditional on participating in biweekly, nurse-led, virtual diabetes education/skills training and stress/coping intervention) compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in inner city African Americans with poorly controlled T2DM. One hundred (100) individuals will be randomized to either the DM-CCT intervention or the UCT intervention and followed for 6-months, with study visits at baseline, 3-months, and 6-months. The primary outcomes will be glycemic control (HbA1c) and quality of life (SF-12) at 6-months post randomization. The secondary outcomes will be self-care behaviors (diet, exercise, medication adherence) and psychological health (stress, coping) measured at 6-months post randomization. In preparation for future cost effectiveness studies, the final aim will estimate the cost of delivery of the DM-CCT and UCT interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Self-report as African American
  • Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
  • Residence in inner city zip codes
  • Income greater or equal to133% of federal poverty level or Medicaid eligible
  • Able to communicate in English.

排除标准

  • Mental confusion on interview suggesting significant dementia
  • Alcohol or drug abuse/dependency
  • Active psychosis or acute mental disorder
  • Participation in other diabetes clinical trials
  • Life expectancy <6 months

结局指标

主要结局

Glycemic control (HbA1c)

时间窗: Change from baseline HbA1c at 6 months post intervention follow-ups

Blood specimens (10cc of blood) will be obtained by trained phlebotomists or nurse for HbA1c.

Quality of Life as measured by SF-12

时间窗: Change from baseline quality of life measure at 6 months post intervention follow-ups

The SF-12 (Ware 1996) is a valid and reliable instrument to measure functional status and reproduces 90% of the variance in PCS-36 and MCS-36 scores.

次要结局

  • Self-Care(Change from baseline self-care at 6 months post intervention follow-ups)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Annette Campbell

Associate Professor

State University of New York at Buffalo

研究点 (2)

Loading locations...

相似试验